(All fields required)
Please enter a valid email.
Please enter your name.
Our studies focus on primary prevention of HPV-related disease through vaccination, and our research group focuses on answering some of the key research questions that have emerged since the development of HPV vaccines:
This longitudinal study of adolescent girls who have received an HPV vaccine, their mothers, and their clinicians, examines girls’ risk perceptions, sexual behaviors and acquisition of sexually transmitted infections after vaccination.Grant support: R01 AI073713Principal Investigator: Jessica Kahn, MD, MPH
This longitudinal study of 11- and 12-year-old girls who have received an HPV vaccine, their mothers, and their clinicians, examines communication among girls, mothers and clinicians as well as girls’ risk perceptions and behaviors after vaccination. Grant support: R01 AI073713 Principal Investigator: Jessica Kahn, MD, MPH
These studies examine whether nonvaccine type HPVs increase in the community after widespread HPV vaccination. Grant support: K23 AI50923, R01 AI073713, and R01 AI104709Principal Investigator: Jessica Kahn, MD, MPH
This is a global, online Community of Practice (CoP) developed in collaboration with the World Health Organization, which currently has more than 1,000 members from 114 countries. The goals of the HPV Vaccine CoP are to enable health professionals globally to: 1) share knowledge, experience and resources regarding cervical cancer prevention; 2) add their opinions to the global policy and practice dialogue on enhancing cervical cancer prevention programs and establishing HPV vaccination programs; and 3) access strategies for cervical cancer prevention program implementation in low- and middle-income countries. Grant support: WHO, PATH, Bill and Melinda Gates Foundation Principal Investigator: Jessica Kahn, MD, MPH
Dr. Kahn serves on the Therapeutic Leadership Group of the ATN and has been involved in several protocols through this national network of investigators conducting research on adolescent HIV. Recent projects include a clinical trial of the quadrivalent HPV vaccine in HIV-positive young women to examine vaccine safety and immunogenicity, a clinical trial of the vaccine in HIV-positive men to examine efficacy, in collaboration with the AIDS Malignancy Consortium, and studies of oral HPV and other tumor viruses in HIV-infected young women and men. Grant support: U01 HD040533Principal Investigator: Craig Wilson, MD
Her Point of View Study
My Voice Counts Study
HPV Surveillance Studies
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY: 1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2015 Cincinnati Children's Hospital Medical Center